Suro Senen

Promising Breakthrough in Non-Small Cell Lung Cancer: Zipalertinib Combination Demonstrates Significant Progression-Free Survival in Phase III Trial

• Medical Research and Clinical Trials

Promising Breakthrough in Non-Small Cell Lung Cancer: Zipalertinib Combination Demonstrates Significant Progression-Free Survival in Phase III Trial

Suro Senen August 14, 2026

A groundbreaking interim analysis from the global Phase III REZILIENT3 trial has unveiled a significant advancement in...

Read More Read more about Promising Breakthrough in Non-Small Cell Lung Cancer: Zipalertinib Combination Demonstrates Significant Progression-Free Survival in Phase III Trial

Beyond the "All Clear": A New Era for Breast Cancer Survivorship in Canada

• Psychosocial Support and Mental Health

Beyond the "All Clear": A New Era for Breast Cancer Survivorship in Canada

Suro Senen August 13, 2026

For decades, the primary focus of the Canadian oncology community has been the "survival" metric—the clinical milestone...

Read More Read more about Beyond the "All Clear": A New Era for Breast Cancer Survivorship in Canada

Alarming Surge in Type 2 Diabetes Among Young People in the UK: A Public Health Crisis Unfolding

• Medical Research and Clinical Trials

Alarming Surge in Type 2 Diabetes Among Young People in the UK: A Public Health Crisis Unfolding

Suro Senen August 13, 2026

London, UK – A groundbreaking study published in the July 2026 edition of The Lancet Regional Health...

Read More Read more about Alarming Surge in Type 2 Diabetes Among Young People in the UK: A Public Health Crisis Unfolding

A New Chapter in B2B Media: WTWH Media Rebrands as Arrowfly

• Treatment Innovations

A New Chapter in B2B Media: WTWH Media Rebrands as Arrowfly

Suro Senen August 13, 2026

In a significant transformation for the business-to-business (B2B) media landscape, Cleveland-based WTWH Media—the parent organization behind Drug...

Read More Read more about A New Chapter in B2B Media: WTWH Media Rebrands as Arrowfly

Strengthening Global Health Architecture: A Strategic Partnership Between Spain and the World Health Organization

• Breast Cancer Prevention and Lifestyle

Strengthening Global Health Architecture: A Strategic Partnership Between Spain and the World Health Organization

Suro Senen August 12, 2026

Introduction: A Strategic Alignment for Global Resilience On April 23 and 24, 2024, the World Health Organization...

Read More Read more about Strengthening Global Health Architecture: A Strategic Partnership Between Spain and the World Health Organization

Bridging the Global Divide: Ireland’s Strategic Partnership with the WHO to Revolutionize Assistive Technology

• Global Breast Cancer Awareness

Bridging the Global Divide: Ireland’s Strategic Partnership with the WHO to Revolutionize Assistive Technology

Suro Senen August 11, 2026

Introduction: The Silent Crisis of Access In an era defined by rapid technological advancement, a significant portion...

Read More Read more about Bridging the Global Divide: Ireland’s Strategic Partnership with the WHO to Revolutionize Assistive Technology

A New Era of Global Health Leadership: Strengthening the Strategic Partnership Between WHO and the Republic of Korea

• Breast Cancer Prevention and Lifestyle

A New Era of Global Health Leadership: Strengthening the Strategic Partnership Between WHO and the Republic of Korea

Suro Senen August 11, 2026

Introduction: A 75-Year Journey of Transformation The relationship between the World Health Organization (WHO) and the Republic...

Read More Read more about A New Era of Global Health Leadership: Strengthening the Strategic Partnership Between WHO and the Republic of Korea

The Great Divergence: Analyzing the Strained Relationship Between the U.S. and the World Health Organization

• Breast Cancer Prevention and Lifestyle

The Great Divergence: Analyzing the Strained Relationship Between the U.S. and the World Health Organization

Suro Senen August 9, 2026

Introduction: A Fracture in Global Health Diplomacy The World Health Organization (WHO), a cornerstone of international cooperation...

Read More Read more about The Great Divergence: Analyzing the Strained Relationship Between the U.S. and the World Health Organization

Dispatch Bio Advances Promising Immunotherapy for Advanced GI Cancers with First Patient Dosed in Phase I Trial

• Medical Research and Clinical Trials

Dispatch Bio Advances Promising Immunotherapy for Advanced GI Cancers with First Patient Dosed in Phase I Trial

Suro Senen August 8, 2026

A novel approach combining oncolytic virotherapy and CAR T-cell technology, DISP-10, shows early promise in tackling challenging...

Read More Read more about Dispatch Bio Advances Promising Immunotherapy for Advanced GI Cancers with First Patient Dosed in Phase I Trial

Beyond Automation: The Paradigm Shift Toward AI-Assisted Decision Intelligence in Pharmacovigilance

• Chemotherapy and Targeted Therapy

Beyond Automation: The Paradigm Shift Toward AI-Assisted Decision Intelligence in Pharmacovigilance

Suro Senen August 8, 2026

In the modern life sciences landscape, the pressure on pharmacovigilance (PV) teams is reaching a critical inflection...

Read More Read more about Beyond Automation: The Paradigm Shift Toward AI-Assisted Decision Intelligence in Pharmacovigilance